Novavax, Inc. (FRA:NVV1)
Germany · Delayed Price · Currency is EUR 7.44
-0.50 (-6.24%)
At close: Jan 30, 2026
Novavax Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 341.75 | -187.5 | -545.06 | -657.94 | -1,744 | -418.26 |
Depreciation & Amortization | 35.01 | 48.5 | 41.23 | 29.05 | 12.66 | 4.89 |
Loss (Gain) From Sale of Assets | 45.09 | -51.95 | - | - | - | - |
Asset Writedown & Restructuring Costs | 2.08 | 4.13 | 10.08 | - | - | - |
Stock-Based Compensation | 38.5 | 48.15 | 85.36 | 130.3 | 183.63 | 128.04 |
Other Operating Activities | 21.91 | 2.92 | 71.27 | 443.8 | 136.79 | 230.78 |
Change in Accounts Receivable | 113.89 | 354.09 | -274.44 | 249.17 | -183.39 | -422.69 |
Change in Inventory | -5.58 | 12.91 | -74.46 | -477.8 | -8.87 | - |
Change in Accounts Payable | -343.49 | -385.63 | -378.81 | 913.4 | 600.33 | 163.16 |
Change in Unearned Revenue | -627.47 | 67.11 | 350.87 | -1,046 | 1,326 | 271.55 |
Operating Cash Flow | -378.32 | -87.26 | -713.97 | -415.94 | 322.95 | -42.54 |
Capital Expenditures | -5.42 | -13.06 | -53.77 | -89.06 | -54.5 | -54.47 |
Sale of Property, Plant & Equipment | 192.64 | 192.64 | - | - | - | - |
Cash Acquisitions | - | - | - | - | - | -165.52 |
Sale (Purchase) of Intangibles | -0.98 | -1.58 | -5.04 | -3.93 | -2.99 | -0.15 |
Investment in Securities | -141 | -382.04 | - | - | 157.64 | -157.64 |
Investing Cash Flow | 45.26 | -204.04 | -58.81 | -92.99 | 100.15 | -377.78 |
Long-Term Debt Issued | - | - | - | 175.25 | - | - |
Long-Term Debt Repaid | - | -3.99 | -352.35 | -93.6 | -127.91 | -96.07 |
Net Debt Issued (Repaid) | 36.05 | -3.99 | -352.35 | 81.66 | -127.91 | -96.07 |
Issuance of Common Stock | - | 264.58 | 360.4 | 249.23 | 589.62 | 881.01 |
Other Financing Activities | -4.47 | - | -3.59 | -5.9 | - | - |
Financing Cash Flow | 30.92 | 260.58 | 4.47 | 324.99 | 461.71 | 984.76 |
Foreign Exchange Rate Adjustments | -3.08 | -7.8 | 3.27 | 4.52 | -5.29 | 2.12 |
Net Cash Flow | -305.23 | -38.52 | -765.04 | -179.41 | 879.52 | 566.56 |
Free Cash Flow | -383.74 | -100.32 | -767.74 | -504.99 | 268.45 | -97.01 |
Free Cash Flow Margin | -36.04% | -14.71% | -78.05% | -25.48% | 23.42% | -20.40% |
Free Cash Flow Per Share | -2.31 | -0.66 | -7.62 | -6.46 | 3.61 | -1.69 |
Cash Interest Paid | 21.19 | 17.57 | 17.35 | 18.04 | 19.43 | 13.71 |
Cash Income Tax Paid | 9.11 | 0.95 | 0.19 | 17.98 | 12.61 | - |
Levered Free Cash Flow | -455.23 | -175.64 | -979.22 | -213.32 | 727.41 | -263.17 |
Unlevered Free Cash Flow | -436.41 | -163.09 | -970.21 | -200.9 | 740.62 | -253.7 |
Change in Working Capital | -862.65 | 48.48 | -376.84 | -361.15 | 1,734 | 12.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.